As important immune cells that prevent tumor progression, CD8+ cytotoxic T lymphocytes (CD8+CD28+ T cells) were decreased in NSCLC patients compared to healthy volunteers although it did not reach significance. This evidence concerns the gene CD28 and non-small cell lung carcinoma.